rheumatoid factor-negative juvenile idiopathic arthritis
ORPHA: 854081 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Tofacitinib | Oral tablet | FDA Approved | 5 | — |
Clinical Presentation
Signs and symptoms associated with rheumatoid factor-negative juvenile idiopathic arthritis, sourced from HPO and Orphanet clinical annotations.
ArthritisJoint swellingJoint stiffnessAnkle swellingArthralgiaAbnormality of the wristElevated erythrocyte sedimentation rateKnee osteoarthritisSynovial lining hyperplasiaEnthesitisSynovitisUveitisAbnormality of the handFlexion contractureAbnormal hip joint morphologyMild postnatal growth retardationWeight lossAbnormal metatarsal morphologyAnemiaLymphadenopathyAbnormal shoulder morphologyAbnormality of the cervical spineMyalgiaAntinuclear antibody positivityHip osteoarthritisAbnormality of the temporomandibular jointLow-grade feverAbnormal metacarpophalangeal joint morphologyOligoarthritisIridocyclitisHepatosplenomegaly
Classification & Codes
Orphanet Code
ORPHA:85408rheumatoid factor-negative juvenile idiopathic arthritis
| Orphanet | ORPHA:85408 |
| Treatments | 1 drug(s) |
| Symptoms on record | 31 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO